Patent · US Active

Treatment of respiratory disorders using TRPA1 antagonists

US9186360B2 · kind B2 · utility

5Cited by

2References

7Claims

0Family size

Assignee

Glenmark Pharmaceuticals S.A. · CH

Inventors

Neelima Khairatkar-Joshi · Thane, IN
Abhay Kulkarni · Navi Mumbai, IN
Indranil Mukhopadhyay · Navi Mumbai, IN
Vidya Ganapati Kattige · Thane, IN
Vikram M. Bhosale · Mumbai, IN
Dinesh Pradeep Wale · Osmanabad, IN
Abraham Thomas · Jamkhed, IN
Sukeerthi Kumar · Navi Mumbai, IN
Sachin Sundarlal Chaudhari · Jamkhed, IN

Key dates

Filing date	Jun 13, 2012
Grant date	Nov 17, 2015
Priority date	—
Expiry date	Nov 23, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present patent application relates to treatment of a respiratory disorder using TRPA1 antagonists. Particularly, the present patent application relates to treatment of a respiratory disorder using a TRPA1 antagonist, wherein the TRPA1 antagonist is administered by inhalation route to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.